Lingxiang Wu

2.1k total citations
44 papers, 708 citations indexed

About

Lingxiang Wu is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Lingxiang Wu has authored 44 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Lingxiang Wu's work include COVID-19 Clinical Research Studies (5 papers), Knee injuries and reconstruction techniques (4 papers) and Cancer-related molecular mechanisms research (4 papers). Lingxiang Wu is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), Knee injuries and reconstruction techniques (4 papers) and Cancer-related molecular mechanisms research (4 papers). Lingxiang Wu collaborates with scholars based in China, United States and Nigeria. Lingxiang Wu's co-authors include Shiyi Chen, Yunsheng Ge, Pengyun Zhang, Qianghu Wang, Wei Wu, Bin Huang, Mengyan Zhu, Kai Gao, Kening Li and Hong Li and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Lingxiang Wu

44 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingxiang Wu China 15 181 153 116 113 82 44 708
Mousa Mohammadnia‐Afrouzi Iran 19 105 0.6× 244 1.6× 195 1.7× 79 0.7× 30 0.4× 56 1.0k
Sweta Gupta United States 16 60 0.3× 159 1.0× 184 1.6× 92 0.8× 29 0.4× 63 854
Liqiong Cai China 11 275 1.5× 253 1.7× 32 0.3× 82 0.7× 49 0.6× 30 735
Jae Hee Lee South Korea 17 41 0.2× 278 1.8× 106 0.9× 115 1.0× 117 1.4× 43 888
Chi‐Long Chen Taiwan 20 118 0.7× 246 1.6× 204 1.8× 35 0.3× 44 0.5× 49 947
Hongqian Liu China 14 66 0.4× 247 1.6× 218 1.9× 43 0.4× 152 1.9× 65 859
James Thommes United States 13 162 0.9× 157 1.0× 41 0.4× 139 1.2× 22 0.3× 32 1.0k
Minjun Huang China 17 54 0.3× 259 1.7× 130 1.1× 116 1.0× 12 0.1× 57 834
Shasha Wang China 13 31 0.2× 170 1.1× 26 0.2× 148 1.3× 73 0.9× 45 631

Countries citing papers authored by Lingxiang Wu

Since Specialization
Citations

This map shows the geographic impact of Lingxiang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingxiang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingxiang Wu more than expected).

Fields of papers citing papers by Lingxiang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingxiang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingxiang Wu. The network helps show where Lingxiang Wu may publish in the future.

Co-authorship network of co-authors of Lingxiang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Lingxiang Wu. A scholar is included among the top collaborators of Lingxiang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingxiang Wu. Lingxiang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xia, Lingxiang Wu, Shipeng Gong, et al.. (2025). Comprehensive visceral transcriptome profiling of three pig breeds along altitudinal gradients in Yunnan. Scientific Data. 12(1). 735–735. 1 indexed citations
2.
Wang, Jing, Lingxiang Wu, Xi Li, et al.. (2024). OA04.05 SHR-A1921, A TROP-2 Targeted Antibody-Drug Conjugate (ADC), In Patients (pts) with Advanced Small-Cell Lung Cancer (SCLC). Journal of Thoracic Oncology. 19(10). S16–S17. 5 indexed citations
3.
Li, Wenjun, et al.. (2024). Genome-Wide Detection for Runs of Homozygosity in Baoshan Pigs Using Whole Genome Resequencing. Genes. 15(2). 233–233. 1 indexed citations
4.
Wu, Lingxiang, Ruichao Chai, Zihan Lin, et al.. (2023). Evolution-driven crosstalk between glioblastoma and the tumor microenvironment. Cancer Biology and Medicine. 20(5). 1–6. 4 indexed citations
6.
Wang, Ziyu, Tingting Zhang, Wei Wu, et al.. (2022). Detection and Localization of Solid Tumors Utilizing the Cancer-Type-Specific Mutational Signatures. Frontiers in Bioengineering and Biotechnology. 10. 883791–883791. 2 indexed citations
7.
Oh, Hwanhee, Inah Hwang, Lingxiang Wu, et al.. (2021). Therapy-Induced Transdifferentiation Promotes Glioma Growth Independent of EGFR Signaling. Cancer Research. 81(6). 1528–1539. 7 indexed citations
8.
Wang, Qianqian, Tianyu Qu, Lingxiang Wu, et al.. (2021). High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis. Frontiers in Oncology. 11. 644575–644575. 16 indexed citations
9.
Wang, Ziyu, Wei Wu, Lingxiang Wu, et al.. (2021). Laboratory Testing Implications of Risk-Stratification and Management of COVID-19 Patients. Frontiers in Medicine. 8. 699706–699706. 3 indexed citations
10.
Shao, Jiaofang, Yuan Liang, Yan Li, et al.. (2021). Implications of liver injury in risk-stratification and management of patients with COVID-19. Hepatology International. 15(1). 202–212. 15 indexed citations
11.
Li, Kening, Bin Huang, Min Wu, et al.. (2020). Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Nature Communications. 11(1). 6044–6044. 154 indexed citations
12.
Zhang, Denan, Hongbo Xie, Lingxiang Wu, et al.. (2020). CHG: A Systematically Integrated Database of Cancer Hallmark Genes. Frontiers in Genetics. 11. 29–29. 38 indexed citations
13.
Liu, Jie, Xiao‐peng Ma, Ji Zhang, et al.. (2019). Manual Acupuncture for Optic Atrophy: A Systematic Review and Meta-Analysis. Evidence-based Complementary and Alternative Medicine. 2019. 1–12. 6 indexed citations
14.
Shi, Yin, Liang Li, Jie Sun, et al.. (2019). Efficacy of electroacupuncture in regulating the imbalance of AMH and FSH to improve follicle development and hyperandrogenism in PCOS rats. Biomedicine & Pharmacotherapy. 113. 108687–108687. 28 indexed citations
15.
Chen, Huan, et al.. (2017). Inferring Alcoholism SNPs and Regulatory Chemical Compounds Based on Ensemble Bayesian Network. Combinatorial Chemistry & High Throughput Screening. 20(2). 107–115. 2 indexed citations
16.
Jiang, Hong, Wei Wu, Rongxin Zhang, et al.. (2017). An Integrating Approach for Genome-Wide Screening of MicroRNA Polymorphisms Mediated Drug Response Alterations. International Journal of Genomics. 2017. 1–7. 5 indexed citations
17.
Wu, Lingxiang, Xiujie Chen, Denan Zhang, et al.. (2016). IGSA: Individual Gene Sets Analysis, including Enrichment and Clustering. PLoS ONE. 11(10). e0164542–e0164542. 4 indexed citations
18.
Shen, Liguo, Yizhe Wu, Feng Zhang, et al.. (2012). Assessment of an asymmetrical coating stent with sirolimus released from ablumial matrix in porcine model. Clinical Research in Cardiology. 101(11). 917–927. 10 indexed citations
19.
Jin, Weizhong, Lingxiang Wu, Yuanlin Song, et al.. (2011). Continuous Intra-Arterial Blood pH Monitoring by a Fiber-Optic Fluorosensor. IEEE Transactions on Biomedical Engineering. 58(5). 1232–1238. 32 indexed citations
20.
Zhong, Wei, Zongjun Liu, Piotr Tomasik, et al.. (2008). Improving the biocompatibility of poly(ε-caprolactone) by surface Immobilization of chitosan and heparin. e-Polymers. 8(1). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026